Nuclease-resistant single-stranded DNA controls for nucleic acid amplification assays

Journal of Clinical Microbiology

Volumn 45, Issue 8, 2007, Pages 2570-2574

  Gotsch, Antje ^a   Schubert, Andreas ^a   Bombis, Armin ^a   Wiedmann, Michael ^a   Zauke, Michael ^a   Schorling, Stefan ^a  

^a ROCHE DIAGNOSTICS GMBH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYRIBONUCLEASE I; NUCLEASE; SINGLE STRANDED DNA;

ARTICLE; BACTERIOPHAGE; CLONING; DELETION MUTANT; ELECTRON MICROSCOPY; ESCHERICHIA COLI; NONHUMAN; NUCLEIC ACID AMPLIFICATION; PARVOVIRUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SPECTROPHOTOMETRY;

BACTERIOPHAGE M13; DEOXYRIBONUCLEASES; DNA, SINGLE-STRANDED; HUMANS; NUCLEIC ACID AMPLIFICATION TECHNIQUES; PARVOVIRUS B19, HUMAN; REFERENCE STANDARDS; TEMPERATURE;

ENTEROBACTERIA PHAGE FD; ESCHERICHIA COLI; PARVOVIRUS;

EID: 34548075279     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.00647-07     Document Type: Article

References (17)

1. Allain, J. P., I. Thomas, and S. Sauleda. 2002. Nucleic acid testing for emerging viral infections. Transfusion Med. 12:275-283.
2. Blümel, J., I. Schmidt, W. Effenberger, H. Seitz, H. Willkommen, H. H. Brackmann, J. Lower, and A. M. Eis-Hübinger. 2002. Parvovirus B19 transmission by heat-treated clotting factor concentrates. Transfusion 42:1473-1481.
3. Brown, K. E. 2004. Detection and quantitation of parvovirus B19. J. Clin. Virol. 31:1-4.
4. Crissman, J. W., and G. P. Smith. 1984. Gene-III protein of filamentous phages: evidence for a carboxyl-terminal domain with a role in morphogenesis. Virology 132:445-455.
5. Hayakawa, F., K. Imada, M. Towatari, and H. Saito. 2002. Life-threatening human parvovirus B19 infection transmitted by intravenous immune globulin. Br. J. Haematol. 118:1187-1189.
6. Lynch, T. 1999. Human parvovirus B19 transmission from SD plasma. FDA/CBER/Blood Products Advisory Committee, 63rd Meeting, vol. 1. Food and Drug Administration, Washington, DC.
7. Melzak, K., C. S. Sherwood, R. S. B. Turner, and C. A. Haynes. 1996. Driving forces for DNA adsorption to silica in perchlorate solutions. J. Colloid Interface Sci. 181:635-644.
8. Nelson, F. K., S. M. Friedman, and G. P. Smith. 1981. Filamentous phage DNA cloning vectors: a noninfective mutant with a nonpolar deletion in gene III. Virology 108:338-350.
9. Pasloske, B. L., C. R. WalkerPeach, R. D. Obermoeller, M. Winkler, and D. B. DuBois. 1998. Armored RNA technology for production of ribonuclease-resistant viral RNA controls and standards. J. Clin. Microbiol. 36:3590-3594.
10. Saldanha, J., and P. Minor. 1996. Detection of human parvovirus B19 DNA in plasma pools and blood products derived from these pools: implications for efficiency and consistency of removal of B19 DNA during manufacture. Br. J. Haematol. 93:714-719.
11. Schorling, S., G. Schalasta, G. Enders, and M. Zauke. 2004. Quantification of parvovirus B19 DNA using COBAS AmpliPrep automated sample preparation and LightCycler real-time PCR. J. Mol. Diagn. 6:37-41.
12. Stöcher, M., and J. Berg. 2004. Internal control DNA for PCR assays introduced into lambda phage particles exhibits nuclease resistance. Clin. Chem. 50:2163-2166.
13. WalkerPeach, C. R., and B. L. Pasloske. 2004. DNA bacteriophage as controls for clinical viral testing. Clin. Chem. 50:1970-1971.
14. WalkerPeach, C. R., M. Winkler, D. B. DuBois, and B. L. Pasloske. 1999. Ribonuclease-resistant RNA controls (armored RNA) for reverse transcription-PCR, branched DNA, and genotyping assays for hepatitis C virus. Clin. Chem. 45:2079-2085.
15. Weindel, K., M. Riedling, and A. Geiger. November 2000. Magnetic glass particles, method for their preparation and uses thereof. European patent specification EP 1 232 502.
16. Wu, C. G., B. Mason, J. Jong, D. Erdman, L. McKernan, M. Oakley, M. Soucie, B. Evatt, and M. Y. Yu. 2005. Parvovirus B19 transmission by a high-purity factor VIII concentrate. Transfusion 45:1003-1010.
17. Young, N. S., and K. E. Brown. 2004. Parvovirus B19. N. Engl. J. Med. 350:586-597.